Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. The company is headquartered in Kenmore, New York and currently employs 13 full-time employees. The firm has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The firm's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
AIFF stock price ended at $1.9 on 木曜日, after dropping 1.55%
On the latest trading day May 07, 2026, the stock price of AIFF fell by 1.55%, dropping from $1.95 to $1.90. During the session, the stock saw a volatility of 6.56%, with prices oscillating between a daily low of $1.83 and a high of $1.95. On the latest trading day, the trading volume for AIFF decreased by 25.8K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 356.1K shares were traded, with a market value of approximately $28.1M.